『肿瘤资讯美中嘉和』神药又添新技能，低剂量阿司匹林可降低肝癌发生风险！( 三 )

[6]Malehmir M, Pfister D, Gallage S, et al. Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. Nat Med 2019;25:641- 55.
[7]Petrick JL, Sahasrabuddhe VV, Chan AT, et al. NSAID use and risk of hepatocellular carcinoma and intrahepatic chol- angiocarcinoma: the Liver Cancer Pooling Project. Cancer Prev Res (Phila) 2015;8: 1156-62.
[8]Sahasrabuddhe VV, Gunja MZ, Graubard BI, et al. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst 2012;104:1808-14.
[9]Simon TG, Ma Y, Ludvigsson JF, et al. Association between aspirin use and risk of hepatocellular carcinoma. JAMA Oncol 2018;4:1683-90.
[10]Lee TY, Hsu YC, Tseng HC, et al. Association of daily aspirin therapy with risk of hepatocellular carcinoma in patients with chronic hepatitis B. JAMA Intern Med 2019;179:633-40.

本文插图

本文插图
入群交流
【『肿瘤资讯美中嘉和』神药又添新技能，低剂量阿司匹林可降低肝癌发生风险！】美中嘉和已经建立肺癌、乳腺癌、妇科肿瘤、消化道肿瘤以及其他癌种的病友交流群。加入美中嘉和病友群，听肿瘤专家讲座，问肿瘤医生问题，学肿瘤治疗进展，说肿瘤治疗心得。